Get the Stockscreener App
1.08
4.85%
-0.055
After Hours:
1.11
0.03
+2.78%
Oncolytics Biotech Inc stock is traded at $1.08, with a volume of 446.21K.
It is down -4.85% in the last 24 hours and down -7.69% over the past month.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
See More
Previous Close:
$1.135
Open:
$1.11
24h Volume:
446.21K
Relative Volume:
0.43
Market Cap:
$108.39M
Revenue:
-
Net Income/Loss:
$-20.31M
P/E Ratio:
-4.0832
EPS:
-0.2645
Net Cash Flow:
$-21.07M
1W Performance:
+6.93%
1M Performance:
-7.69%
6M Performance:
+102.25%
1Y Performance:
+4.85%
1-Day Range:
$1.08
$1.13
1-Week Range:
$0.97
$1.15
52-Week Range:
$0.3258
$1.51
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Compare ONCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.08 | 118.63M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Initiated | Lake Street | Buy |
| Oct-06-22 | Initiated | Maxim Group | Buy |
| Feb-17-21 | Initiated | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Stock (ONCY) Latest News
Analyzing Oncolytics Biotech Inc. with risk reward ratio chartsWall Street Watch & Verified Momentum Stock Ideas - newser.com
Will Oncolytics Biotech Inc. outperform the market2025 Breakouts & Breakdowns & Low Risk High Win Rate Picks - newser.com
What recovery options are there for Oncolytics Biotech Inc.Insider Buying & Real-Time Volume Analysis Alerts - newser.com
Can Oncolytics Biotech Inc. stock rebound after recent weaknessMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
Why Oncolytics Biotech Inc. is moving today2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Combining price and volume data for Oncolytics Biotech Inc.July 2025 Action & Verified Swing Trading Watchlist - newser.com
Oncolytics Biotech Reports Increased Q3 Loss Amid Rising Expenses - TipRanks
Using Ichimoku Cloud for Oncolytics Biotech Inc. technicalsJuly 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com
What analysts say about Oncolytics Biotech Inc stockVolatility Trading Techniques & Affordable Market Insights - earlytimes.in
Will Oncolytics Biotech Inc. stock keep outperforming rivals2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com
Visual trend scoring systems applied to Oncolytics Biotech Inc.Weekly Risk Summary & Weekly High Potential Stock Alerts - newser.com
Using data tools to time your Oncolytics Biotech Inc. exit2025 Growth vs Value & Long-Term Growth Stock Strategies - newser.com
Will Oncolytics Biotech Inc. stock recover faster than peersEarnings Miss & Verified Trade Idea Suggestions - newser.com
How to interpret RSI for Oncolytics Biotech Inc. stockJuly 2025 Opening Moves & Free Weekly Watchlist of Top Performers - newser.com
Is Oncolytics Biotech Inc. stock overvalued by current metricsLayoff News & Free Community Supported Trade Ideas - newser.com
Backtesting results for Oncolytics Biotech Inc. trading strategiesTrade Ideas & Verified Stock Trade Ideas - newser.com
Heatmap analysis for Oncolytics Biotech Inc. and competitorsQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
Identifying reversal signals in Oncolytics Biotech Inc.2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Is Oncolytics Biotech Inc. stock gaining market shareJuly 2025 Levels & Reliable Momentum Entry Alerts - newser.com
Oncolytics Biotech Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Oncolytics Biotech Inc. (NASDAQ:ONCY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Oncolytics Biotech Inc. stock reach Wall Street targetsForecast Cut & Fast Exit/Entry Strategy Plans - newser.com
Can you recover from losses in Oncolytics Biotech Inc.2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Oncolytics Biotech Inc Stock (ONCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):